Drug Type Small molecule drug |
Synonyms MCL1 inhibitor - Gilead Sciences, GS 9716, GS-9716 |
Target |
Mechanism Mcl-1 inhibitors(Induced myeloid leukemia cell differentiation protein Mcl-1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC38H46ClN5O6S |
InChIKeyGRGIAFGOQJYTKU-ZRZJLSGHSA-N |
CAS Registry2388470-64-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | US | 15 Sep 2021 | |
Advanced Malignant Solid Neoplasm | Phase 1 | IL | 15 Sep 2021 |